Literature DB >> 3875286

C1q nephropathy: a distinct pathologic entity usually causing nephrotic syndrome.

J C Jennette, C G Hipp.   

Abstract

The presence, distribution, and intensity of glomerular C1q localization were evaluated by direct immunofluorescence microscopy in 800 renal biopsy specimens which were also studied by light and electron microscopy. Identified were 15 patients with extensive (mean: 3.6 + out of 4 +), predominantly mesangial, C1q localization along with C3 and immunoglobulins, but no evidence for systemic lupus erythematosus. Pathologically, this lesion most closely resembled lupus nephritis. Clinical and pathologic data from these 15 C1q nephropathy patients were compared to data from 30 lupus nephritis and 223 other proliferative glomerulonephritis patients, and the C1q nephropathy patients were found to be dissimilar to both groups. The 15 C1q nephropathy patients had an average age of 17.8 years, 8 males, 7 females, 9 Black, 100% had proteinuria (mean 7.5 g/d), 40% hematuria, 0% hypocomplementemia, and 0% antinuclear antibodies. By electron microscopy, 100% had mesangial dense deposits, 20% capillary wall dense deposits, and 0% endothelial tubuloreticular inclusions. Nine patients treated with steroids had no definite resolution of proteinuria. We proposed that C1q nephropathy is a distinct clinicopathologic entity, usually causing steroid-resistant nephrotic syndrome in older children and young adults.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3875286     DOI: 10.1016/s0272-6386(85)80150-5

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  42 in total

Review 1.  Histopathology of lupus nephritis.

Authors:  Konstantinos Giannakakis; Tullio Faraggiana
Journal:  Clin Rev Allergy Immunol       Date:  2011-06       Impact factor: 8.667

Review 2.  C1q nephropathy in the pediatric population: pathology and pathogenesis.

Authors:  Scott E Wenderfer; Rita D Swinford; Michael C Braun
Journal:  Pediatr Nephrol       Date:  2010-02-24       Impact factor: 3.714

3.  Is collapsing C1q nephropathy another MYH9-associated kidney disease? A case report.

Authors:  Amber M Reeves-Daniel; Samy S Iskandar; Donald W Bowden; Meredith A Bostrom; Pamela J Hicks; Mary E Comeau; Carl D Langefeld; Barry I Freedman
Journal:  Am J Kidney Dis       Date:  2010-01-29       Impact factor: 8.860

4.  C1q nephropathy in children: clinical characteristics and outcome.

Authors:  Vindya N Gunasekara; Neil J Sebire; Kjell Tullus
Journal:  Pediatr Nephrol       Date:  2013-12-11       Impact factor: 3.714

Review 5.  Bartter syndrome complicated by immune complex nephropathy. Case report and literature review.

Authors:  Yahya Sardani; Kenan Qin; Mark Haas; Andrew J Aronson; Robert L Rosenfield
Journal:  Pediatr Nephrol       Date:  2003-06-26       Impact factor: 3.714

6.  C1q nephropathy in two young sisters.

Authors:  Jameela A Kari; Sawsan M Jalalah
Journal:  Pediatr Nephrol       Date:  2007-10-21       Impact factor: 3.714

7.  Rituximab treatment of collapsing C1q glomerulopathy: clinical and histopathological evolution.

Authors:  Martin Bitzan; Jodie D Ouahed; Preetha Krishnamoorthy; Chantal Bernard
Journal:  Pediatr Nephrol       Date:  2008-03-20       Impact factor: 3.714

8.  A case of congenital nephrotic syndrome associated with positive C1q immunofluorescence.

Authors:  M Kuwano; Y Ito; Y Amamoto; K Aida
Journal:  Pediatr Nephrol       Date:  1993-08       Impact factor: 3.714

9.  C1q nephropathy and minimal change nephrotic syndrome.

Authors:  Craig S Wong; Christopher A Fink; Jane Baechle; Alexis A Harris; Amy O Staples; John R Brandt
Journal:  Pediatr Nephrol       Date:  2008-12-11       Impact factor: 3.714

10.  A single-center study of C1q nephropathy in children.

Authors:  Isabel Roberti; Noosha Baqi; Shefali Vyas; Dae Un Kim
Journal:  Pediatr Nephrol       Date:  2008-08-08       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.